[Form 4] Lumentum Holdings Inc. Insider Trading Activity
Rhea-AI Filing Summary
Michael E. Hurlston, President and CEO and a Director of Lumentum Holdings Inc. (LITE), reported an acquisition of 34,393 restricted stock units (RSUs) on 08/19/2025. Each RSU represents a contingent right to receive one share of the issuer's common stock following vesting. After this grant the reporting person beneficially owns 149,597 shares in total. The RSUs vest with one-third of the shares vesting one year from the grant date and the remaining shares vesting in eight equal quarterly installments thereafter on the 15th of November, February, May and August, subject to continued employment and the issuer’s 2015 Equity Incentive Plan. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact.
Positive
- CEO received 34,393 RSUs, aligning executive compensation with shareholder value
- Post-grant beneficial ownership of 149,597 shares increases insider stake
Negative
- None.
Insights
TL;DR: A routine executive RSU grant aligns CEO incentives with shareholders; vesting schedule ties value to continued service.
The filing documents a standard equity compensation award to the CEO and a director. The grant of 34,393 RSUs increases the reporting person’s stake to 149,597 shares and uses a time-based vesting schedule: one-third after one year and the remainder in eight equal quarterly installments on specified calendar dates. From a governance perspective, this is a conventional retention and alignment tool under the company’s 2015 Equity Incentive Plan. There is no disclosure of cash exercise price or sales, and no derivative transactions reported. The disclosure does not indicate any accelerated vesting, change-in-control provisions, or sale of shares.
TL;DR: Form 4 correctly reports a time-based RSU grant and provides required vesting details; signature executed by attorney-in-fact.
The Form 4 lists an acquisition code A(1) for 34,393 RSUs with a $0 price, consistent with restricted stock unit grants where shares are delivered upon vesting. The filing includes the reporting person’s relationship to the issuer (Director; President and CEO) and the post-transaction beneficial ownership figure. The document was signed by an attorney-in-fact, and the explanatory note clarifies the RSU vesting schedule and governing plan. No amendments or other transaction types are reported.